Form 4 for OCUL OCULAR THERAPEUTIX, INC

Accepted 2022-06-21 00:00:00 ET · period of report 2022-06-16 · accession 0001104659-22-073146 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-21	2022-06-16	OCUL	Heier Jeffrey S.	Dir	A - Grant	$0.00	+8,933	47.9K	+23%	$0
D	2022-06-21	2022-06-16	OCUL	Heier Jeffrey S.	Dir	A - Grant	$0.00	+26.8K	26.8K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-06-16	A	A	8,933	$0.00	47,933	D	—	—	(F1) On June 16, 2022, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
2	Derivative	Stock Option (Right to Buy)	2022-06-16	A	A	26,800	$0.00	26,800	D	$3.43 · — to 2032-06-15	26,800 Common Stock	(F2) Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.